"Designing Growth Strategies is in our DNA"

Hemorrhoid Treatment Market Size, Share & Industry Analysis, By Product Type (Suppository, Sprays, Creams & Ointments, and Others) By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Local Anesthetics, Corticosteroids, and Others) By Type (Internal {Grade I, Grade II, Grade III, and Grade IV}, and External) By Distribution Channel (Hospital Pharmacy, Drug Stores & Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2024-2032

Last Updated: October 27, 2025 | Format: PDF | Report ID: FBI110985

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 6.1% from 2024 to 2032

Unit

Value (USD billion)

Segmentation

By Product Type

  • Suppository
  • Sprays
  • Creams & Ointments
  • Others

By Drug Class

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Local Anesthetics
  • Corticosteroids
  • Others

By Type

  • Internal
  • External

By Distribution Channel

  • Hospital Pharmacy
  • Drug Store and Retail Pharmacy
  • Online Pharmacy

By Region

  • North America (By Product Type, By Drug Class, By Type, By Distribution Channel, By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Drug Class, By Type, By Distribution Channel,  and By Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Drug Class, By Type, By Distribution Channel,  and By Country/ Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Drug Class, By Type, By Distribution Channel,  and By Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Drug Class, By Type, By Distribution Channel, and By Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • 2019-2032
  • 2023
  • 2019-2022
  • 161
GET A FREE SAMPLE

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports